De Burlo Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-7,385
Closed -$1.98M 100
2016
Q1
$1.98M Sell
7,385
-23,100
-76% -$6.61M 0.57% 60
2015
Q4
$9.53M Sell
30,485
-6,700
-18% -$1.99M 2.24% 12
2015
Q3
$10.1M Buy
+37,185
New +$11.4M 2.37% 9
2015
Q2
Sell
-48,585
Closed -$14.5M 111
2015
Q1
$14.5M Buy
48,585
+3,015
+7% +$860K 2.86% 4
2014
Q4
$11.7M Buy
+45,570
New +$11.4M 2.37% 9

Other funds holding AGN

De Burlo Group's AGN Position: Q2 2016 in Review

De Burlo Group sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 7,385 shares — an estimated $1.98M sold.

De Burlo Group first reported a position in AGN in Q4 2014 and held it in 5 quarters. The position peaked at $14.5M in Q1 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • De Burlo Group reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • De Burlo Group sold 7,385 Allergan plc shares in Q2 2016, an estimated $1.98M.
  • De Burlo Group first reported a position in Allergan plc in Q4 2014 and held it in 5 quarters.
  • De Burlo Group's Allergan plc position peaked at $14.5M in Q1 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on De Burlo Group's 13F filing for Q2 2016, filed 4 Aug 2016.